Sitagliptin in pharma franchise in Hyderabad

Sitagliptin in PCD pharma franchise in Odisha

Sitagliptin in top pharma company in Jaipur

Sitagliptin in pcd pharma supplier in Tamil Nadu

Sitagliptin in phama franchise company in india
Sitagliptin in phama distributor in Lucknow

Istalab D Tablet

Composition : Sitagliptin Phosphate I.P. 100mg + Dapagliflozin Propanediol U.S.P. 10mg Tablets

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10x10

Price : ₹249/-

Please Contact For Best Price

Istalab D Tablet is a potent combination medication that includes Sitagliptin Phosphate I.P. at a dosage of 100 mg and Dapagliflozin Propanediol U.S.P. at 10 mg. This innovative formulation is specifically designed for the management of type 2 diabetes mellitus in adults. Sitagliptin, a DPP-4 inhibitor, enhances the body’s ability to regulate blood sugar levels by increasing insulin secretion in response to meals and decreasing glucagon levels, which helps to lower glucose production in the liver. Dapagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, works by preventing the reabsorption of glucose in the kidneys, leading to increased glucose excretion through urine. This dual mechanism of action not only helps in achieving better glycemic control but also offers additional benefits such as weight loss and a reduction in blood pressure.

The combination of Sitagliptin and Dapagliflozin in Istalab D Tablet provides a comprehensive approach to diabetes management, making it particularly suitable for patients who require more than one medication to control their blood sugar levels effectively. This combination therapy is beneficial for individuals who may have not achieved adequate glycemic control with monotherapy or those who are starting treatment for the first time. By addressing multiple pathways involved in glucose metabolism, Istalab D Tablet helps patients maintain stable blood sugar levels, which is crucial for preventing the long-term complications associated with diabetes.

While Istalab D Tablet is generally well-tolerated, some patients may experience side effects. Common adverse reactions include urinary tract infections, genital mycotic infections, gastrointestinal disturbances such as nausea, and headache. Rare but serious side effects may include dehydration, kidney problems, and pancreatitis. Patients should be vigilant for symptoms such as excessive thirst, frequent urination, or abdominal pain and should seek medical attention if these arise.

For optimal storage, Istalab D Tablet should be kept in a cool, dry place, away from direct sunlight and moisture. It is essential to store this medication out of reach of children and pets to prevent accidental ingestion.

Read More

About the Product

Istalab D Tablet is a potent combination medication that includes Sitagliptin Phosphate I.P. at a dosage of 100 mg and Dapagliflozin Propanediol U.S.P. at 10 mg. This innovative formulation is specifically designed for the management of type 2 diabetes mellitus in adults. Sitagliptin, a DPP-4 inhibitor, enhances the body’s ability to regulate blood sugar levels by increasing insulin secretion in response to meals and decreasing glucagon levels, which helps to lower glucose production in the liver. Dapagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, works by preventing the reabsorption of glucose in the kidneys, leading to increased glucose excretion through urine. This dual mechanism of action not only helps in achieving better glycemic control but also offers additional benefits such as weight loss and a reduction in blood pressure.

The combination of Sitagliptin and Dapagliflozin in Istalab D Tablet provides a comprehensive approach to diabetes management, making it particularly suitable for patients who require more than one medication to control their blood sugar levels effectively. This combination therapy is beneficial for individuals who may have not achieved adequate glycemic control with monotherapy or those who are starting treatment for the first time. By addressing multiple pathways involved in glucose metabolism, Istalab D Tablet helps patients maintain stable blood sugar levels, which is crucial for preventing the long-term complications associated with diabetes.

While Istalab D Tablet is generally well-tolerated, some patients may experience side effects. Common adverse reactions include urinary tract infections, genital mycotic infections, gastrointestinal disturbances such as nausea, and headache. Rare but serious side effects may include dehydration, kidney problems, and pancreatitis. Patients should be vigilant for symptoms such as excessive thirst, frequent urination, or abdominal pain and should seek medical attention if these arise.

For optimal storage, Istalab D Tablet should be kept in a cool, dry place, away from direct sunlight and moisture. It is essential to store this medication out of reach of children and pets to prevent accidental ingestion.

Common side effects may include urinary tract infections, gastrointestinal disturbances, and headache. Serious side effects should be reported to a healthcare provider.

Istalab D Tablet is indicated for the management of type 2 diabetes mellitus in adults.

Consult a healthcare professional before starting this medication, especially if you have a history of kidney issues or pancreatitis.

Store in a cool, dry place away from sunlight and moisture

Get in Touch